Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $62.1M | $70.9M | $61.4M | $56.6M | $55.4M | $53.0M | $52.0M | $53.4M |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $62.1M | $70.9M | $61.4M | $56.6M | $55.4M | $53.0M | $52.0M | $53.4M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $51.4M | $59.9M | $51.0M | $46.4M | $45.6M | $43.2M | $42.3M | $44.2M |
| EBITDA | $0 | $59.9M | $0 | $0 | $0 | $0 | $0 | −$88.9M |
| Net income | $102.9M | $60.3M | $4.2M | $126.4M | −$82.5M | $157.6M | −$54.6M | −$44.7M |
| Net margin | 165.7% | 85.0% | 6.8% | 223.2% | -148.8% | 297.2% | -105.0% | -83.7% |
| EPS (diluted) | 2.13 | 1.25 | 0.09 | 2.60 | -1.69 | 3.23 | -1.11 | -0.91 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds MICDX.
No tracked institution reports a position in MICDX as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2025-12-17 | $0.3270 | 2025-12-17 |
| 2025-06-25 | $0.2833 | 2025-06-25 |
| 2024-12-18 | $0.1602 | 2024-12-18 |
| 2024-06-26 | $0.2915 | 2024-06-26 |
| 2023-12-14 | $0.1195 | 2023-12-14 |
No one on the platform has traded MICDX yet.
| -0.16% |
| $115M |
| — |
| JSMVXJackson Square SMID-Cap Growth Fund | $19.26 | +2.58% | $108M | — |
| KMVAXKirr Marbach Partners Value Fund | $40.41 | +1.43% | $116M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.